News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,041 Results
Type
Article (2505)
Company Profile (39)
Press Release (36497)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14277)
Career Advice (80)
Deals (2104)
Drug Delivery (9)
Drug Development (4206)
Employer Resources (10)
FDA (442)
Job Trends (774)
News (20415)
Policy (1067)
Tag
Academia (149)
Allergies (6)
Alliances (3525)
ALS (4)
Alzheimer's disease (47)
Antibody-drug conjugate (ADC) (18)
Approvals (444)
Artificial intelligence (13)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (484)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (158)
Cardiovascular disease (5)
Career advice (66)
Career pathing (1)
CAR-T (18)
Cell therapy (54)
Cervical cancer (2)
Clinical research (3260)
Collaboration (99)
Company closure (1)
Compensation (53)
COVID-19 (183)
CRISPR (8)
C-suite (33)
Cystic fibrosis (2)
Data (139)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (473)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4352)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6182)
Executive appointments (101)
FDA (499)
Funding (83)
Gene editing (19)
Gene therapy (23)
GLP-1 (60)
Government (152)
Guidances (7)
Healthcare (709)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (20)
Indications (2)
Infectious disease (190)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (6)
Intellectual property (10)
Interviews (7)
IPO (1002)
IRA (7)
Job creations (290)
Job search strategy (64)
Kidney cancer (4)
Labor market (5)
Layoffs (41)
Leadership (1)
Legal (213)
Liver cancer (6)
Lung cancer (16)
Lymphoma (4)
Management (4)
Manufacturing (22)
MASH (5)
Medical device (311)
Medtech (311)
Mergers & acquisitions (1180)
Metabolic disorders (35)
Multiple sclerosis (9)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (96)
NextGen: Class of 2025 (358)
Non-profit (156)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (11)
Pain (11)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (5)
Peanut (1)
People (5717)
Pharmaceutical (5)
Phase I (1419)
Phase II (1639)
Phase III (856)
Pipeline (104)
Policy (12)
Postmarket research (30)
Preclinical (629)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (27)
Real estate (424)
Recruiting (5)
Regulatory (823)
Reports (7)
Research institute (147)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (12)
Series A (25)
Series B (9)
Service/supplier (2)
Sickle cell disease (3)
Special edition (2)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (491)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
Vaccines (30)
Venture capitalists (9)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (11)
Last 7 days (89)
Last 30 days (303)
Last 365 days (2564)
2025 (1002)
2024 (2647)
2023 (2899)
2022 (3814)
2021 (4120)
2020 (3529)
2019 (2100)
2018 (1574)
2017 (1830)
2016 (1635)
2015 (1859)
2014 (1400)
2013 (1213)
2012 (1420)
2011 (1354)
2010 (1193)
Location
Africa (43)
Alabama (1)
Arizona (16)
Asia (1920)
Australia (303)
California (945)
Canada (144)
China (41)
Colorado (22)
Connecticut (11)
Delaware (4)
Europe (3910)
Florida (45)
Georgia (7)
Idaho (3)
Illinois (14)
India (2)
Indiana (34)
Japan (12)
Kansas (12)
Maryland (28)
Massachusetts (347)
Michigan (10)
Minnesota (15)
Missouri (3)
Nebraska (2)
Nevada (3)
New Hampshire (2)
New Jersey (74)
New York (52)
North Carolina (96)
North Dakota (1)
Northern California (415)
Ohio (28)
Oklahoma (2)
Oregon (5)
Pennsylvania (60)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (394)
Tennessee (2)
Texas (82)
United States (1952)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (59)
Wisconsin (6)
39,041 Results for "locus biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Locus Biosciences Announces $23.9 Million in Funding from BARDA to Support First Phase 2 Trial of CRISPR-engineered Bacteriophage Therapy
Locus Biosciences, Inc. today announced the release of $23.9 million from the Biomedical Advanced Research and Development Authority (BARDA) to continue the development of Locus’ CRISPR-enhanced bacteriophage therapy, LBP-EC01, for treating urinary tract infections (UTIs) caused by drug-resistant Escherichia coli (E. coli) based on positive results from a Phase 2a clinical trial.
January 23, 2024
·
5 min read
Press Releases
Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases
August 12, 2024
·
7 min read
BioMidwest
Basking Biosciences Presents Novel Reversible RNA-aptamer Thrombolytic at Locus Walk RNA Innovation Conference
Basking Biosciences (Basking), a clinical-stage biopharmaceutical company, today discussed the development status of BB-031, the company’s novel, RNA-based thrombolytic for use in patients experiencing acute ischemic stroke, at the Locus Walk RNA Innovation Conference, held virtually.
May 9, 2023
·
4 min read
Press Releases
Factor Bioscience to Present Non-Viral Gene Editing and Cell Engineering Innovations at the ASGCT Annual Meeting
May 6, 2025
·
2 min read
Bio NC
Locus Biosciences Announces $35 Million Financing
Locus Biosciences, Inc. today announced that it completed a $35 million financing which included a Series B equity financing and conversion of an earlier convertible note.
May 18, 2022
·
4 min read
Press Releases
Castle Biosciences to Acquire Previse
May 6, 2025
·
4 min read
Press Releases
Alligator Bioscience Updates Dividend Policy
May 8, 2025
·
2 min read
Press Releases
Marvel Biosciences Announces Closing of Private Placement
May 13, 2025
·
4 min read
Press Releases
Aura Biosciences to Participate in Upcoming May 2025 Investor Conferences
May 2, 2025
·
1 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - May 9, 2025
May 12, 2025
·
1 min read
1 of 3,905
Next
